Frans Bots's Email Addresses & Phone Numbers

📖 Summary

-Dynamic and visionary business leader with significant experience and expertise in Strategy, Market Access, Sales & Marketing, New Business Development, Regulatory, Medical and Clinical Affairs, Registration, Pricing & Reimbursement including 15 years Multi-Country General Management -Experience covers infectious diseases, hematology,oncology, BMT, orphan disease, personalized medicine, genomic tests, DNA next generation sequencing, gene therapy -Recognized top performer -Exceptional results in highly competitive markets -Double-digit growth year after year -Record of proactivity, creativity, innovation and entrepreneurship -Strong strategic thinking, communication skills -Integrity, open minded, cross-cultural competence -Polyglot + studying Japanese and Russian SELECTED MAJOR ACCOMPLISHMENTS ● Significant record of strong revenue growth, increased market share and profitability in mostly very challenging situations ● Building a European pharmaceutical company subsidiary from scratch ● Major focus on registration, pricing and reimbursement, market access ● Successful start-up of several new businesses ● Creation of a highly innovative scientific relaunch marketing strategy generating > $ 700 MM of additional cum worldwide revenue ● Creative relaunch Leucovorin (colon CA) doubling flat revenue of € 5 MM to € 11 MM in 2 years ● Subs becomes number one in oncology worldwide ● Launch Navelbine (breast CA, lung CA) Belgium and obtaining the.highest market share and sales per capita worldwide in a market dominated by big pharma ● Creative strategy to obtain reimbursement of Navelbine in the Netherlands when reimbursement was impossible according to official regulation ● Successful launch and market penetration of Busilvex in leukemia, lymphoma and of 2 antibiotics for hospital infections ● Creation of the most effective anti-generic strategy worldwide ● Proposal of major collaboration deals with high commercial potential to global HQsGlobal Pharma & Biotech Strategist and Achiever/Creator of Opportunities @ -Dynamic and visionary business leader with significant experience and expertise in Strategy, Market Access, Sales & Marketing, New Business Development, Regulatory,Medical & Clinical Affairs, Registration, Pricing & Reimbursement including 15 years General Management -Recognized top performer -Exceptional results in highly competitive markets -Double-digit growth year after year Hands-on experience in Business development,sales, product & marketing management,marketing plans,marketing research,local and global marketing strategy, positioning,patient profiles,market development,market access,product (pre)launch and relaunch,product life cycle management,coaching,sales force effectiveness,people management,start-ups, project management, key opinion leader development, clinical research, clinical trials, medical plans, pricing & reimbursement, lobbying health care and reimbursement authorities, building business units and a company subsidiary from scratch 4 projects -Monoclonal antibodies collaboration project -Market Access project oncology market -Development of strategy and action plan to buy a pharmaceutical company/product line (budget 50-100 million €) -Broadest cancer related genes test on the market (combining next generation sequencing & molecular pathology) Global contacts with pharmaceutical, biotechnology and diagnostic companies for partnerships Global contacts with world-leading clinical trials groups to have this innovative tumor DNA testing incorporated into clinical trials designs From January 2013 to Present (2 years 10 months) Brussels Area, BelgiumMentor/Consultant @ Adventura Capital-linking International Capital to Spanish Technology Companies The Mentor is a successful entrepreneur who uses his know-how and extensive network to help these companies From January 2014 to Present (1 year 10 months) Barcelona Area, SpainAssociate/Consultant @ Alacrita-leading transatlantic management consulting firm providing expertise-based services to the pharmaceutical,biotechnology and life science sectors From February 2014 to Present (1 year 9 months) London, United KingdomDirector Oncology & Hematology Benelux @ Result -Proposing a gene therapy and a monoclonal antibody collaboration opportunity to corporate HQ From 2010 to December 2012 (2 years) BelgiumManaging Director Benelux @ Building from scratch a pharmaceutical company,specialized in drugs for the treatment of cancer Setting-up of administrative, regulatory affairs, sales & clinical research teams Initiating and supervising clinical studies and investigator driven trials to support the marketing of key drugs Translating Strategy in operational goals and objectives Market Access Major focus on registration, pricing and reimbursement, market access Intensive contacts with registration and reimbursement authorities Critical contribution to scientific documents for regulatory purposes Developing marketing & medical plans and long range business plans Budgeting, forecasting Strategic planning, marketing strategy,(pre) launch,post-launch, life cycle management Sales Force effectiveness, sales force action plans to correct deviations from budget Medical & Regulatory Affairs, Pharmacovigilance P & L responsibility Cost Control KOL development Transferring Adverse Drug Reactions Contract/ price negotiating Developing and implementing a highly effective anti-generic strategy Participating in cross functional & multinational teams concerned with new product launches Evaluating a number of own and in- licencing drugs/treatments ( cancer, cardiovascular, urology,gynecology,gene therapy) Distribution logistics Result -Navelbine Belgium: highest market share and sales per capita worldwide -Navelbine Netherlands: creative strategy to obtain reimbursement in a situation where reimbursement was impossible according to official regulation -Successful launch and market penetration of Busilvex in leukemia, lymphoma -Most effective anti generic strategy of all affiliates worldwide with > 90% of volume sales still protected years after generic market entry -Excellent results with little resources In a very competitive market dominated by big pharma From 1995 to 2010 (15 years) BrusselsMarketing Director Oncology @ Marketing plans ( Novantrone, Methotrexate, Ledervorin) Relaunch Ledervorin (colon cancer) Creative scientific new marketing and positioning strategy Result: -Doubling flat product sales of 5 million € to 11 million € in 2 years -Belgium Oncology division becomes number one oncology division worldwide ( highest market share and sales/capita) -Proposing in-licencing opportunities to global HQ (:oral cytostatic, inhibitor of multidrug resistance) -Proposing the development of prodrugs and analogues of company anticancer drugs to global HQ From 1993 to 1995 (2 years) BelgiumProject Manager Photodynamic Therapy @ Start-up of this innovative new treatment approach for cancer in university medical centers Furthermore responsible for all pre marketing activities, as well as for clinical research Photodynamic therapy is a unique treatment modality for cancer, which combines a light sensitive drug with laser therapy From 1991 to 1993 (2 years) BelgiumBusiness Unit Manager @ Start-up of a new business unit Test market Belgium Result: -Excellent -Other Cyanamid affiliates also started a dental business unit ( UK, Spain, Portugal) From 1988 to 1990 (2 years) BelgiumProduct Manager Infectious Diseases and Oncology @ Result Sales versus budget: 135% From 1985 to 1987 (2 years) BelgiumProduct Manager Infectious Diseases @ Result Creation of a highly innovative scientific relaunch marketing strategy generating > $ 700 MM of additional cum worldwide revenue From 1984 to 1985 (1 year) BelgiumNational Sales Manager Hospitals @ Launch Piperacillin From 1982 to 1983 (1 year) Pays BasPostgraduate Business Administration @ KU LeuvenPrimary Medical Knowledge, Anatomy, Physiology, Pathology @ Leidse OnderwijsinstellingenBachelor's Degree French Language @ COCMASpanish, Italian, Chinese (Mandarin) and currently studying Japanese and Russian @ GLTTInternational School Frans Bots is skilled in: Oncology, Biotechnology, Management, Pharmaceutical Industry, Analysis, Hematology, orphan drugs, infectious diseases, Gene Therapy, Generics, Urology, Marketing Strategy, Cardiovascular, Gynecology, Pediatric..., Bone Marrow..., Laser Therapy, general management, P&L Responsibility, Strategic Thinking, Gastroenterology, registration, Product Launch, Regulatory Affairs, pricing, reimbursement, sales management, product management, project management, marketing management, Marketing Research, market access, new business development, hospital sales, Coaching, clinical research, Clinical Trials, medical plans, pharmacovigilance, in-licencing, business plans, Entrepreneurship, Leadership, Infectious Diseases, Market Access, Pharmacovigilance